Filing Details
- Accession Number:
- 0001225208-19-000576
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-04 16:12:52
- Reporting Period:
- 2019-01-03
- Accepted Time:
- 2019-01-04 16:12:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566080 | J. Kevin Ballinger | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp & Pres, Interven Cardio | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-03 | 2,140 | $34.21 | 82,223 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-03 | 12,600 | $33.55 | 69,623 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.10 to $34.29, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.05 to $34.04, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
